Treatment of vomiting and nausea with minimum dose of olanzapine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11975112
APP PUB NO 20210244679A1
SERIAL NO

17148262

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compositions, devices, and methods for transdermal administration of olanzapine and uses thereof, e.g., to treat nausea and vomiting.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
STARTON THERAPEUTICS INC215 COLLEGE ROAD SUITE 300 PARAMUS NJ 07652

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Borovinskaya, Marina East Brunswick, US 20 11
Hartwig, Rod L Sloatsburg, US 10 6
Lather, Tamanna Jersey City, US 24 15
Modi, Nisarg Bellerose, US 28 28
Oliver, James Raleigh, US 66 587
Plakogiannis, Fotios Whitestone, US 8 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Nov 7, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 7, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 7, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00